日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Wafer-Level Self-Assembly and Interface Passivation Patterning Technology for Nanomaterial-Compatible 3D MEMS Sensing Chips

用于纳米材料兼容型3D MEMS传感芯片的晶圆级自组装和界面钝化图案化技术

Zhang, Zheng; Zhang, Yanlin; Luo, Yuanyuan; Lv, Guoliang; Yin, Jianglin; Tan, Pengwei; Duan, Guotao

DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.

DCLK1 通过去泛素化 HDAC6 来驱动膀胱癌的恶性进展和化疗耐药性。

Du Ashuai, Zhou Yuzheng, Deng Xinpei, Yuan Dongbo, Li Kai, Luo Yuanyuan, Tan Songsong, Dai Xuchao, Yu Bo, Jiang Kehua, Tan Xingliang, Zhu Jianguo

PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP78

PRAS40激活IRE1α-XBP-1介导的未折叠蛋白反应,通过增强ST6Gal1依赖的GRP78的α-2,6唾液酸化作用,加剧结直肠癌。

Teng, Hongming; Guo, Yuxin; Chen, Xinran; Fan, Anlian; Zhang, Chengfei; Zhang, Ting; Luo, Yuanyuan; Huang, Lin

Metabolic dysregulation associated with core symptom cluster in lung cancer patients undergoing chemotherapy

肺癌化疗患者核心症状群相关的代谢紊乱

Xiao, Yanxuan; Luo, Yuanyuan; Mao, Dongmei; Zhang, Le; Bai, Ruiyan; Yang, Zhihui; Zhao, Yang; Zhang, Fengyi; Zhang, Lili; Wang, Zhijian

Orchestrating immunopathology: the spectrum of programmed cell death pathways co-opted by influenza a virus in pulmonary immunity

调控免疫病理:甲型流感病毒在肺部免疫中利用的程序性细胞死亡通路谱系

Luo, Yuanyuan; Xiang, Li; He, Qingman; Gao, Yongxiang; Zheng, Chuan; Yao, Huan

Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial

乌帕替尼治疗难治性白塞氏综合征:一项多中心、单臂试验

Li, Jiachen; Xia, Weiyi; Ji, Huijuan; Gong, Xiaoxin; Dong, Qi; Wu, Yanan; Wang, Longjun; Peng, Meixia; Geng, Sifan; Liu, Jingxuan; Ma, Ke; Yu, Qi; Cui, Xinglei; Luo, Yuanyuan; Zhu, Wenhua; Zhang, Shumin; Chen, Shi; Li, Yuhui; Li, Zhanguo; Liu, Tian

Effects of renal impairment and hemodialysis on the pharmacokinetics and safety of HRS-8427, a siderophore cephalosporin for Gram-negative bacterial infections

肾功能损害和血液透析对铁载体头孢菌素类药物HRS-8427(用于治疗革兰氏阴性菌感染)的药代动力学和安全性的影响

Wu, Yuanhao; Han, Qiwen; Yang, Haijing; Xue, Jun; Wang, Lili; Mao, Xiaomeng; Yin, Tengrui; Jiang, Hao; Xu, Sheng; Huang, Yuanyuan; Wang, Ting; He, Yan; Luo, Yuanyuan; Chen, Wenli; Zhang, Jing

SR-B1 knockdown suppresses breast cancer cell proliferation, migration, and invasion via the PI3K/AKT pathway

SR-B1敲低通过PI3K/AKT通路抑制乳腺癌细胞的增殖、迁移和侵袭。

Du, Ashuai; Guo, Dianbin; Yuan, Dongbo; Li, Kai; Luo, Yuanyuan; Tan, Songsong; Dai, Xuchao; Yu, Bo; You, Wanxiang; Zhao, Junjie; Yan, Bo; Jiang, Kehua; Fan, Xiaofei; Zhu, Jianguo; Li, Ming; Xu, Yanmei; Li, Jinwen; Li, Juan

Statin therapy in systemic lupus erythematosus: a meta-analysis of disease activity and inflammatory biomarkers

他汀类药物治疗系统性红斑狼疮:疾病活动度和炎症生物标志物的荟萃分析

Qian, Suhai; Wu, Jingyi; Hu, Chao; Luo, Yuanyuan; Chang, Runyu; Liu, Ting; Ding, Xinghong

Coronary microvascular dysfunction mediates in-hospital adverse outcomes in ST-segment elevation myocardial infarction patients without standard modifiable cardiovascular risk factors

冠状动脉微血管功能障碍介导了无标准可改变心血管危险因素的ST段抬高型心肌梗死患者的院内不良预后。

Shah, Ankit; Maski, Manish; Goldschmidt, Debbie; Egbuna, Ogo; Holub, Ashley; Swallow, Elyse; Barber, Beth; Imaoka, Takuro; Sakashita, Shingo; Matsuoka, Satoshi; Sato, Kimi; Naito, Yoichi; Okumura, Genki; Koyama, Shohei; Hozawa, Koji; Nakamura, Yuka; Shibutani, Yuma; Ishizu, Tomoko; Sekine, Ikuo; Tajiri, Kazuko; Yao, Guoli; Guo, Mengru; Song, Na; Liu, Jie; Wu, Wanling; Pan, Defeng; Luo, Yuanyuan